Informações de Dexcom Inc

Mais detalhes de Dexcom Inc Empresa

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.



Código da empresaDXCM

Nome da EmpresaDexcom Inc

Data de listagemApr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Número de funcionários10300

Tipo de títulosOrdinary Share

Fim do ano fiscalApr 14

Endereço6340 Sequence Dr

CidadeSAN DIEGO

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal92121

Telefone18582000200

Sitehttps://www.dexcom.com/

Código da empresaDXCM

Data de listagemApr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Executivos da empresa Dexcom Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

276.26K

+6.52%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

Ms. Bridgette P. Heller

Independent Director

28.04K

+21.94%

Mr. Kyle Malady

Independent Director

22.67K

-2.86%

Ms. Rimma Driscoll

Independent Director

9.04K

+127.87%

Ms. Renee D. Gala

Independent Director

6.88K

+20.30%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

276.26K

+6.52%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

Por RegiãoUSD

Nome

Receita

Proporção

United States

841.00M

72.68%

Outside of United states

316.10M

27.32%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

Distribuição de ações

Atualizado em: ter, 19 de ago

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

12.28%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.30%

Baillie Gifford & Co.

4.26%

Geode Capital Management, L.L.C.

2.75%

Outro

70.24%

Investidores

Proporção

The Vanguard Group, Inc.

12.28%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.30%

Baillie Gifford & Co.

4.26%

Geode Capital Management, L.L.C.

2.75%

Outro

70.24%

Tipos de investidores

Investidores

Proporção

Investment Advisor

56.32%

Investment Advisor/Hedge Fund

28.54%

Research Firm

3.44%

Hedge Fund

3.01%

Pension Fund

2.02%

Bank and Trust

1.84%

Sovereign Wealth Fund

1.50%

Venture Capital

0.40%

Individual Investor

0.36%

Outro

2.55%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

2148

383.02M

97.67%

-30.18M

2025Q2

2212

390.97M

99.70%

-27.53M

2025Q1

2252

386.55M

98.59%

-25.17M

2024Q4

2220

380.88M

97.47%

-26.96M

2024Q3

2145

382.31M

97.83%

-30.58M

2024Q2

2115

397.02M

99.11%

-4.31M

2024Q1

2093

389.18M

98.33%

-19.87M

2023Q4

2081

398.01M

103.26%

+83.33K

2023Q3

1994

389.89M

100.89%

-11.88M

2023Q2

1952

389.17M

100.78%

-12.73M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

48.15M

12.28%

+859.71K

+1.82%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

24.25M

6.18%

-475.12K

-1.92%

Jun 30, 2025

State Street Investment Management (US)

16.86M

4.3%

+175.27K

+1.05%

Jun 30, 2025

Baillie Gifford & Co.

16.71M

4.26%

+2.53M

+17.81%

Jun 30, 2025

Geode Capital Management, L.L.C.

10.77M

2.75%

+358.62K

+3.45%

Jun 30, 2025

Jennison Associates LLC

11.52M

2.94%

+994.30K

+9.45%

Jun 30, 2025

Sands Capital Management, LLC

9.95M

2.54%

-466.21K

-4.48%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

8.03M

2.05%

-28.35K

-0.35%

Aug 31, 2025

Nuveen LLC

7.30M

1.86%

-549.07K

-7.00%

Jun 30, 2025

MFS Investment Management

6.49M

1.65%

+3.30M

+103.55%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: seg, 6 de out

Nome

Proporção

First Trust Nasdaq Lux Digi Health Solutions ETF

6.79%

Langar Global HealthTech ETF

5.33%

Global X Internet of Things ETF

5.24%

Global X HealthTech ETF

3.89%

Fidelity Digital Health ETF

3.79%

Harbor Health Care ETF

3.48%

iShares U.S. Medical Devices ETF

3.39%

Touchstone Sands Capital US Select Growth ETF

3.06%

Goldman Sachs Future Health Care Equity ETF

2.68%

Motley Fool Global Opportunities ETF

2.43%

Ver Mais

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporção6.79%

Langar Global HealthTech ETF

Proporção5.33%

Global X Internet of Things ETF

Proporção5.24%

Global X HealthTech ETF

Proporção3.89%

Fidelity Digital Health ETF

Proporção3.79%

Harbor Health Care ETF

Proporção3.48%

iShares U.S. Medical Devices ETF

Proporção3.39%

Touchstone Sands Capital US Select Growth ETF

Proporção3.06%

Goldman Sachs Future Health Care Equity ETF

Proporção2.68%

Motley Fool Global Opportunities ETF

Proporção2.43%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Mar 28, 2022

Split

1→4

Data

Tipo

Proporção

Mar 28, 2022

Split

1→4